SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 33 filers reported holding SUMMIT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,038,479 | -30.1% | 555,336 | -6.2% | 0.00% | – |
| Q2 2023 | $1,485,884 | +10.3% | 591,986 | -23.1% | 0.00% | – |
| Q1 2023 | $1,347,098 | +44.8% | 769,771 | +251.6% | 0.00% | – |
| Q4 2022 | $930,482 | +122.6% | 218,937 | -37.7% | 0.00% | – |
| Q3 2022 | $418,000 | +100.0% | 351,337 | +67.9% | 0.00% | – |
| Q2 2022 | $209,000 | -74.0% | 209,193 | -36.1% | 0.00% | – |
| Q1 2022 | $803,000 | -16.6% | 327,579 | -8.5% | 0.00% | – |
| Q4 2021 | $963,000 | -30.8% | 358,184 | +28.9% | 0.00% | – |
| Q3 2021 | $1,392,000 | -14.2% | 277,946 | +27.8% | 0.00% | – |
| Q2 2021 | $1,623,000 | +28.5% | 217,537 | +1.1% | 0.00% | – |
| Q1 2021 | $1,263,000 | +5.8% | 215,184 | -15.3% | 0.00% | – |
| Q4 2020 | $1,194,000 | +65.1% | 254,107 | +21.0% | 0.00% | – |
| Q3 2020 | $723,000 | – | 210,051 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polar Capital Holdings Plc | 5,800,000 | $27,260,000 | 0.16% |
| Inscription Capital, LLC | 17,000 | $80,000 | 0.03% |
| ExodusPoint Capital Management, LP | 185,844 | $873,000 | 0.01% |
| HoyleCohen, LLC | 10,359 | $49,000 | 0.01% |
| Virtu Financial LLC | 10,835 | $51,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,783 | $18,000 | 0.00% |
| Renaissance Technologies | 253,212 | $1,190,000 | 0.00% |
| Baillie Gifford | 372,261 | $1,749,000 | 0.00% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 37,238 | $175,000 | 0.00% |
| BREWIN DOLPHIN LTD | 1,970 | $9,259 | 0.00% |